Article

DNA-testing company 23andMe has signed a $300 million deal with a drug giant

Business Insider (2019)

A $300 million deal between 23andMe and the pharmaceutical giant GlaxoSmithKline is the latest example. If that has you thinking about how these companies use your data, here's how to delete it.

View Original Source


View All Articles

Comments

No comments yet. Be the first to comment!

Chunks with this Article

2 chunks • used in 1 course
Drug Research and the Pharma industry
A collection of articles about Drug Research and the Pharma industry
CourseChunks
10 resources
Genealogy tracking, DNA and direct-to-consumer genetic-testing
Genealogy tracking, DNA and direct-to-consumer genetic-testing industry
CourseChunks
17 resources

RELATED RESOURCES

with chunks in common

MORE RELATED CONTENT

with shared categories

MORE RESOURCES FROM SOURCE

More from Resources from Summit Global Education   Business Insider